Niina Veitonmäki

Dec
20
PBA-0405 receives FDA "study may proceed"

PBA-0405 receives FDA "study may proceed"

We are proud to announce that  Zermatt Consulting has played a significant role in Pure Biologics approval receival from the
1 min read
Dec
19
Warm holiday wishes from Zermatt Consulting!

Warm holiday wishes from Zermatt Consulting!

The year 2023 has been very busy and productive. Zermatt consulting was part of an exiting journey from drug discovery,